- 308 pages
- English
- ePUB (mobile friendly)
- Only available on web
The Eye
About This Book
The Eye, Volume Four, the latest release in the Stem Cell Innovation in Health and Disease series, addresses the recent data accumulated on the potential applications of stem cells to treat eye diseases. This volume highlights the recent development of cutting-edge in vitro and in vivo research tools and approaches, including human and murine organoid cultures, genetic editing in vitro and in vivo, human iPSC models of disease, haploid cells for genetic as well as compound screening paradigms, genetically engineered mice, and stem cell transplantation to cure eye diseases.
The volume is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine and organ transplantation, and is contributed by world-renowned authors in the field. This is a timely and fascinating collection of information and new discoveries that provides a contemporary snapshot album on the fast-moving field of regenerative medicine and stem cell therapeutics.
- Provides cutting-edge research to understand stem cell functions used in disease treatments of the eye
- Develops processes to bring stem cells from bench to bedside
- Includes up-to-date references on stem cell biology and function in common eye diseases and disorders
Frequently asked questions
Information
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- List of contributors
- About the editors
- Foreword
- Preface
- Epigraph
- Chapter 1. Stem cell-based organoid cultures as innovative approaches for ocular repair and regeneration
- Chapter 2. Organoid-based modality of eye function and cellular processes
- Chapter 3. Leveraging neural crest pluripotency to extend retinal and craniofacial niches for building neurovascular organoidsâa theranostic and drug development perspective
- Chapter 4. Role of stem cell engineering and or gene-editing technologies in eye diseases degeneration, and therapy
- Chapter 5. Stem cells and genetic engineering empower therapeutic development for blinding eye diseases
- Chapter 6. Human stem cell-derived retinal pigment epithelial cells for retinal regeneration: differentiation and clinical translation
- Chapter 7. Mesenchymal stem cells therapy for retinal diseases
- Chapter 8. Retinal cone photoreceptors from pluripotent stem cells for macular regeneration
- Chapter 9. Update on stem/progenitor cell-based clinical trials for eye disease
- Chapter 10. Stem cell innovation in eye disease, repair and regeneration: general conclusion, challenges and prospective
- Index